We previously showed that supplementing SEP to breast cancer cells effectively suppressed PA production, while elevating NO synthesis and also downmodulating HER2 and cell proliferation to the levels similar to normal cells (12,18). The gene discussed is ERBB2; the disease is breast cancer.